.@swog.org S2207 is enrolling patients with relapsed/refractory large B-cell #lymphoma. 3-arm trial adds tazemetostat or zanubrutinib to tafasitamab-lenalidomide.
PI: Jennifer Amengual, MD @columbiacancer.bsky.social
swog.org/clinical-tri... #LBCL #lymsm #hematology @womeninlymphoma.bsky.social

If you're preparing for graduate school interviews, here's a resource to help you prepare.

journals.physiology.org/doi/full/10....

A typical project for an incoming graduate student might involve 1–2 weeks of planning and 2–5 years of execution, [yet] the problem you choose will influence the impact of your work just as much as the quality of your execution. @mfgrp.bsky.social
open.spotify.com/episode/6KMh...

Proud of this work spearheaded by the phenomenal @jlfan.bsky.social and @mingxz.bsky.social in collaboration w/ Ben Izar! The past 3 years we've worked hard to unravel how #CNVs shape #tumor phenotypic plasticity seen in #singlecell #RNAseq data ➡️ #Echidna 🦔

In case you missed it.. New preprint! Our latest study identifying how MHC-I is captured by autophagy and targeted for degradation in #PDAC - It all happens at the ER ! Congrats to co-first authors Marine Berquez, Alex Li & Matthew Luy.
www.biorxiv.org/content/10.1...

Are you a senior PhD student or postdoc? Do you have a cool science story to tell? Do you want to visit Buffalo when the weather is perfect? Then apply for the Emerging Leaders Seminar Series at Roswell Park! DM or email me with questions. (RT please!)

www.roswellpark.org/education/pr...

We've spent 2024 discussing RT trial results in gastroesophageal cancer.

My radiation oncology mate Som helps me make sense of it all below...

2024 Top Story in Oncology: The Role of Radiotherapy in Operable Gastro-Oesophageal and Gastric Cancer — Time for Change

prac.co/l/22cfph7u

Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @djenetbousbaine.bsky.social led the charge... @natureportfolio.bsky.social 1/55

New NCI K32. Up to $80K for salary. $30K/yr research development.
US citizenship NOT required. 🧪

grants.nih.gov/grants/guide...

@thejohnnyyu.bsky.social, @therealnima.bsky.social
, Kevan Shokat, and I are excited to announce a historic achievement by our team at @vevotherapeutics.bsky.social: tinyurl.com/4rrvap3t

Download our database of 492 (!) funding opportunities for EARLY-CAREER FACULTY AND RESEARCHERS.

For each entry, we provide link to funder, description, amount, deadline, and eligibility criteria (e.g. citizenship).

Download freely here: research.jhu.edu/rdt/funding-...